Paul R Allyn1, Erin L Duffy, Romney M Humphries, Patil Injean, S Samuel Weigt, Rajan Saggar, Michael Y Shino, Joseph P Lynch, Abbas Ardehali, Bernard Kubak, Chi-Hong Tseng, John A Belperio, David J Ross, Aric L Gregson. 1. 1 Division of Infectious Diseases, Department of Medicine, University of California Los Angeles, Los Angeles, CA. 2 Department of Medicine Statistics Core, University of California Los Angeles, Los Angeles, CA. 3 Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA. 4 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California Los Angeles, Los Angeles, CA. 5 Division of Cardiothoracic Surgery, Department of Surgery, University of California Los Angeles.
Abstract
BACKGROUND: Community-acquired respiratory virus (CARV) infections occur frequently after lung transplantation and may adversely impact outcomes. We hypothesized that while asymptomatic carriage would not increase the risk of chronic lung allograft dysfunction (CLAD) and graft loss, severe infection would. METHODS: All lung transplant cases between January 2000 and July 2013 performed at our center were reviewed for respiratory viral samples. Each isolation of virus was classified according to clinical level of severity: asymptomatic, symptomatic without pneumonia, and viral pneumonia. Multivariate Cox modeling was used to assess the impact of CARV isolation on progression to CLAD and graft loss. RESULTS: Four thousand four hundred eight specimens were collected from 563 total patients, with 139 patients producing 324 virus-positive specimens in 245 episodes of CARV infection. Overall, the risk of CLAD was elevated by viral infection (hazard ratio [HR], 1.64; P < 0.01). This risk, however, was due to viral pneumonia alone (HR, 3.94; P < 0.01), without significant impact from symptomatic viral infection (HR, 0.97; P = 0.94) nor from asymptomatic viral infection (HR, 0.99; P = 0.98). The risk of graft loss was not increased by asymptomatic CARV infection (HR, 0.74; P = 0.37) nor symptomatic CARV infection (HR, 1.39; P = 0.41). Viral pneumonia did, however, significantly increase the risk of graft loss (HR, 2.78; P < 0.01). CONCLUSIONS: With respect to CARV, only viral pneumonia increased the risk of both CLAD and graft loss after lung transplantation. In the absence of pneumonia, respiratory viruses had no impact on measured outcomes.
BACKGROUND: Community-acquired respiratory virus (CARV) infections occur frequently after lung transplantation and may adversely impact outcomes. We hypothesized that while asymptomatic carriage would not increase the risk of chronic lung allograft dysfunction (CLAD) and graft loss, severe infection would. METHODS: All lung transplant cases between January 2000 and July 2013 performed at our center were reviewed for respiratory viral samples. Each isolation of virus was classified according to clinical level of severity: asymptomatic, symptomatic without pneumonia, and viral pneumonia. Multivariate Cox modeling was used to assess the impact of CARV isolation on progression to CLAD and graft loss. RESULTS: Four thousand four hundred eight specimens were collected from 563 total patients, with 139 patients producing 324 virus-positive specimens in 245 episodes of CARV infection. Overall, the risk of CLAD was elevated by viral infection (hazard ratio [HR], 1.64; P < 0.01). This risk, however, was due to viral pneumonia alone (HR, 3.94; P < 0.01), without significant impact from symptomatic viral infection (HR, 0.97; P = 0.94) nor from asymptomatic viral infection (HR, 0.99; P = 0.98). The risk of graft loss was not increased by asymptomatic CARV infection (HR, 0.74; P = 0.37) nor symptomatic CARV infection (HR, 1.39; P = 0.41). Viral pneumonia did, however, significantly increase the risk of graft loss (HR, 2.78; P < 0.01). CONCLUSIONS: With respect to CARV, only viral pneumonia increased the risk of both CLAD and graft loss after lung transplantation. In the absence of pneumonia, respiratory viruses had no impact on measured outcomes.
Authors: Ramsey R Hachem; Anthony P Khalifah; Murali M Chakinala; Roger D Yusen; Aviva A Aloush; Thalachallour Mohanakumar; G Alexander Patterson; Elbert P Trulock; Michael J Walter Journal: Transplantation Date: 2005-11-27 Impact factor: 4.939
Authors: A G N Robertson; S M Griffin; D M Murphy; J P Pearson; I A Forrest; J H Dark; P A Corris; C Ward Journal: Am J Transplant Date: 2009-05-20 Impact factor: 8.086
Authors: A L Gregson; X Wang; P Injean; S S Weigt; M Shino; D Sayah; A DerHovanessian; J P Lynch; D J Ross; R Saggar; A Ardehali; G Li; R Elashoff; J A Belperio Journal: Am J Transplant Date: 2015-02-12 Impact factor: 8.086
Authors: Tim S Nawrot; Robin Vos; Lotte Jacobs; Stijn E Verleden; Shana Wauters; Veerle Mertens; Christophe Dooms; Peter H Hoet; Dirk E Van Raemdonck; Christel Faes; Lieven J Dupont; Benoit Nemery; Geert M Verleden; Bart M Vanaudenaerde Journal: Thorax Date: 2011-03-23 Impact factor: 9.139
Authors: S S Weigt; C A Finlen Copeland; A Derhovanessian; M Y Shino; W A Davis; L D Snyder; A L Gregson; R Saggar; J P Lynch; D J Ross; A Ardehali; R M Elashoff; S M Palmer; J A Belperio Journal: Am J Transplant Date: 2013-02-07 Impact factor: 8.086
Authors: Michael Y Shino; S Samuel Weigt; Ning Li; Vyacheslav Palchevskiy; Ariss Derhovanessian; Rajan Saggar; David M Sayah; Aric L Gregson; Michael C Fishbein; Abbas Ardehali; David J Ross; Joseph P Lynch; Robert M Elashoff; John A Belperio Journal: Am J Respir Crit Care Med Date: 2013-11-01 Impact factor: 21.405
Authors: S Samuel Weigt; Xiaoyan Wang; Vyacheslav Palchevskiy; Naman Patel; Ariss Derhovanessian; Michael Y Shino; David M Sayah; Joseph P Lynch; Rajan Saggar; David J Ross; Bernie M Kubak; Abbas Ardehali; Scott Palmer; Shahid Husain; John A Belperio Journal: Transplantation Date: 2018-06 Impact factor: 4.939
Authors: Eric D Morrell; Carolyn Brager; Kathleen J Ramos; Xin-Ya Chai; Siddhartha G Kapnadak; Jeffrey Edelman; Gustavo Matute-Bello; William A Altemeier; Billanna Hwang; Michael S Mulligan; Pavan K Bhatraju; Mark M Wurfel; Carmen Mikacenic; Erika D Lease; Ajit P Limaye; Cynthia E Fisher Journal: Am J Respir Cell Mol Biol Date: 2022-05 Impact factor: 6.914
Authors: Satona Tanaka; Jason M Gauthier; Anja Fuchs; Wenjun Li; Alice Y Tong; Margaret S Harrison; Ryuji Higashikubo; Yuriko Terada; Ramsey R Hachem; Daniel Ruiz-Perez; Jon H Ritter; Marina Cella; Marco Colonna; Isaiah R Turnbull; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel Journal: Am J Transplant Date: 2019-12-09 Impact factor: 8.086
Authors: Michael Y Shino; Ning Li; Jamie L Todd; Megan L Neely; Jerry Kirchner; Heather Kopetskie; Michelle L Sever; Courtney W Frankel; Laurie D Snyder; Elizabeth N Pavlisko; Tereza Martinu; Lianne G Singer; Wayne Tsuang; Marie Budev; Pali D Shah; John M Reynolds; Nikki Williams; Mark A Robien; Scott M Palmer; Stephen Sam Weigt; John A Belperio Journal: Am J Transplant Date: 2021-06-16 Impact factor: 9.369
Authors: Anna Stjärne Aspelund; Helena Hammarström; Malin Inghammar; Hillevi Larsson; Lennart Hansson; Bertil Christensson; Lisa I Påhlman Journal: Am J Transplant Date: 2017-09-15 Impact factor: 8.086
Authors: Jesper Magnusson; Johan Westin; Lars-Magnus Andersson; Magnus Lindh; Robin Brittain-Long; Rickard Nordén; Gerdt C Riise Journal: Transplant Direct Date: 2018-07-11